Annual Total Liabilities
$1.74 M
-$333.20 K-16.06%
31 December 2023
Summary:
BioNexus Gene Lab annual total liabilities is currently $1.74 million, with the most recent change of -$333.20 thousand (-16.06%) on 31 December 2023. During the last 3 years, it has fallen by -$1.71 million (-49.56%). BGLC annual total liabilities is now -49.56% below its all-time high of $3.45 million, reached on 01 December 2020.BGLC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.61 M
+$12.90 K+0.81%
30 September 2024
Summary:
BioNexus Gene Lab quarterly total liabilities is currently $1.61 million, with the most recent change of +$12.90 thousand (+0.81%) on 30 September 2024. Over the past year, it has dropped by -$170.90 thousand (-9.61%). BGLC quarterly total liabilities is now -53.47% below its all-time high of $3.45 million, reached on 01 December 2020.BGLC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.1% | -9.6% |
| 3 y3 years | -49.6% | -40.8% |
| 5 y5 years | +1236.8% | - |
BGLC Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -49.6% | at low | -40.8% | +16.9% |
| 5 y | 5 years | -49.6% | +1499.5% | -53.5% | +1869.2% |
| alltime | all time | -49.6% | +1499.5% | -53.5% | +1869.2% |
BioNexus Gene Lab Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.61 M(+0.8%) |
| June 2024 | - | $1.59 M(-12.3%) |
| Mar 2024 | - | $1.82 M(+4.3%) |
| Dec 2023 | $1.74 M(-16.1%) | $1.74 M(-2.0%) |
| Sept 2023 | - | $1.78 M(-8.1%) |
| June 2023 | - | $1.94 M(+18.7%) |
| Mar 2023 | - | $1.63 M(-21.5%) |
| Dec 2022 | $2.08 M(-13.3%) | $2.08 M(+51.0%) |
| Sept 2022 | - | $1.37 M(-11.1%) |
| June 2022 | - | $1.55 M(-24.4%) |
| Mar 2022 | - | $2.05 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.39 M(-30.7%) | - |
| Dec 2021 | - | $2.39 M(-11.7%) |
| Sept 2021 | - | $2.71 M(+3.0%) |
| June 2021 | - | $2.63 M(-15.2%) |
| Mar 2021 | - | $3.11 M(-10.0%) |
| Dec 2020 | $3.45 M(+3070.9%) | $3.45 M(+4131.7%) |
| Sept 2020 | - | $81.60 K(-9.9%) |
| June 2020 | - | $90.60 K(-3.8%) |
| Mar 2020 | - | $94.20 K(-13.5%) |
| Dec 2019 | $108.90 K(-16.4%) | $108.90 K |
| Dec 2018 | $130.30 K | - |
FAQ
- What is BioNexus Gene Lab annual total liabilities?
- What is the all time high annual total liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual total liabilities year-on-year change?
- What is BioNexus Gene Lab quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly total liabilities year-on-year change?
What is BioNexus Gene Lab annual total liabilities?
The current annual total liabilities of BGLC is $1.74 M
What is the all time high annual total liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual total liabilities is $3.45 M
What is BioNexus Gene Lab annual total liabilities year-on-year change?
Over the past year, BGLC annual total liabilities has changed by -$333.20 K (-16.06%)
What is BioNexus Gene Lab quarterly total liabilities?
The current quarterly total liabilities of BGLC is $1.61 M
What is the all time high quarterly total liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly total liabilities is $3.45 M
What is BioNexus Gene Lab quarterly total liabilities year-on-year change?
Over the past year, BGLC quarterly total liabilities has changed by -$170.90 K (-9.61%)